Extendicare Inc (EXE) - Net Assets

Latest as of December 2025: CA$373.37 Million CAD ≈ $270.09 Million USD

Based on the latest financial reports, Extendicare Inc (EXE) has net assets worth CA$373.37 Million CAD (≈ $270.09 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$1.07 Billion ≈ $771.50 Million USD) and total liabilities (CA$693.14 Million ≈ $501.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Extendicare Inc (EXE) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$373.37 Million
% of Total Assets	35.01%
Annual Growth Rate	-2.08%
5-Year Change	266.33%
10-Year Change	113.65%
Growth Volatility	58.46

Extendicare Inc - Net Assets Trend (1998–2025)

This chart illustrates how Extendicare Inc's net assets have evolved over time, based on quarterly financial data. See EXE cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Extendicare Inc (1998–2025)

The table below shows the annual net assets of Extendicare Inc from 1998 to 2025. For live valuation and market cap data, see how much is Extendicare Inc worth.

Year	Net Assets	Change
2025-12-31	CA$373.37 Million ≈ $270.09 Million	+200.25%
2024-12-31	CA$124.35 Million ≈ $89.95 Million	+41.44%
2023-12-31	CA$87.92 Million ≈ $63.60 Million	-12.69%
2022-12-31	CA$100.70 Million ≈ $72.85 Million	-1.20%
2021-12-31	CA$101.92 Million ≈ $73.73 Million	-20.49%
2020-12-31	CA$128.19 Million ≈ $92.73 Million	+11.07%
2019-12-31	CA$115.41 Million ≈ $83.49 Million	-8.40%
2018-12-31	CA$125.99 Million ≈ $91.14 Million	-2.30%
2017-12-31	CA$128.96 Million ≈ $93.28 Million	-26.21%
2016-12-31	CA$174.76 Million ≈ $126.42 Million	+1.53%
2015-12-31	CA$172.13 Million ≈ $124.52 Million	+6974.16%
2014-12-31	CA$-2.50 Million ≈ $-1.81 Million	-106.70%
2013-12-31	CA$37.38 Million ≈ $27.04 Million	-31.62%
2012-12-31	CA$54.66 Million ≈ $39.54 Million	+13.12%
2011-12-31	CA$48.32 Million ≈ $34.95 Million	-84.68%
2010-12-31	CA$315.31 Million ≈ $228.09 Million	+870.87%
2009-12-31	CA$-40.90 Million ≈ $-29.59 Million	-38.50%
2008-12-31	CA$-29.53 Million ≈ $-21.36 Million	-25.25%
2007-12-31	CA$-23.58 Million ≈ $-17.06 Million	+0.32%
2006-12-31	CA$-23.65 Million ≈ $-17.11 Million	-104.86%
2005-12-31	CA$486.54 Million ≈ $351.95 Million	+6.47%
2004-12-31	CA$456.99 Million ≈ $330.58 Million	+28.21%
2003-12-31	CA$356.43 Million ≈ $257.84 Million	+0.73%
2002-12-31	CA$353.83 Million ≈ $255.96 Million	+0.90%
2001-12-31	CA$350.70 Million ≈ $253.69 Million	-8.20%
2000-12-31	CA$382.02 Million ≈ $276.35 Million	-12.66%
1999-12-31	CA$437.38 Million ≈ $316.39 Million	-33.59%
1998-12-31	CA$658.62 Million ≈ $476.44 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Extendicare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 29967600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	CA$662.85 Million	177.53%
Other Comprehensive Income	CA$-6.09 Million	-1.63%
Other Components	CA$16.29 Million	4.36%
Total Equity	CA$373.37 Million	100.00%

Extendicare Inc Competitors by Market Cap

The table below lists competitors of Extendicare Inc ranked by their market capitalization.

Company	Market Cap
Neuland Laboratories Limited NSE:NEULANDLAB	$2.32 Billion
WOOLWORTHS HDGS GDR F:WN30	$2.32 Billion
Paz Oil TA:PZOL	$2.32 Billion
Netmarble Games Corp KO:251270	$2.32 Billion
Carmila SA PA:CARM	$2.32 Billion
Stadler Rail AG SW:SRAIL	$2.32 Billion
Beijing Venustech Inc SHE:002439	$2.32 Billion
Henan Dayou Energy Co Ltd SHG:600403	$2.32 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Extendicare Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 124,352,000 to 373,370,000, a change of 249,018,000 (200.3%).
Net income of 96,656,000 contributed positively to equity growth.
Dividend payments of 41,699,000 reduced retained earnings.
Share repurchases of 191,524,000 reduced equity.
New share issuances of 191,524,000 increased equity.
Other comprehensive income increased equity by 667,000.
Other factors increased equity by 193,394,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CA$96.66 Million	+25.89%
Dividends Paid	CA$41.70 Million	-11.17%
Share Repurchases	CA$191.52 Million	-51.3%
Share Issuances	CA$191.52 Million	+51.3%
Other Comprehensive Income	CA$667.00K	+0.18%
Other Changes	CA$193.39 Million	+51.8%
Total Change	CA$-	200.25%

Book Value vs Market Value Analysis

This analysis compares Extendicare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 7.87x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 3.96x to 7.87x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1998-12-31	CA$8.55	CA$33.82	x
1999-12-31	CA$5.84	CA$33.82	x
2000-12-31	CA$5.21	CA$33.82	x
2001-12-31	CA$5.01	CA$33.82	x
2002-12-31	CA$4.92	CA$33.82	x
2003-12-31	CA$5.05	CA$33.82	x
2004-12-31	CA$6.58	CA$33.82	x
2005-12-31	CA$7.13	CA$33.82	x
2006-12-31	CA$-0.34	CA$33.82	x
2007-12-31	CA$-0.34	CA$33.82	x
2008-12-31	CA$-0.41	CA$33.82	x
2009-12-31	CA$-0.47	CA$33.82	x
2010-12-31	CA$1.36	CA$33.82	x
2011-12-31	CA$0.57	CA$33.82	x
2012-12-31	CA$0.54	CA$33.82	x
2013-12-31	CA$0.43	CA$33.82	x
2014-12-31	CA$-0.03	CA$33.82	x
2015-12-31	CA$1.74	CA$33.82	x
2016-12-31	CA$1.75	CA$33.82	x
2017-12-31	CA$1.29	CA$33.82	x
2018-12-31	CA$1.28	CA$33.82	x
2019-12-31	CA$1.29	CA$33.82	x
2020-12-31	CA$1.43	CA$33.82	x
2021-12-31	CA$1.01	CA$33.82	x
2022-12-31	CA$1.13	CA$33.82	x
2023-12-31	CA$1.03	CA$33.82	x
2024-12-31	CA$1.30	CA$33.82	x
2025-12-31	CA$4.30	CA$33.82	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Extendicare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 25.89%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.82%
• Asset Turnover: 1.56x
• Equity Multiplier: 2.86x
Recent ROE (25.89%) is above the historical average (20.78%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1998	9.95%	3.09%	0.95x	3.38x	CA$-353.30K
1999	-36.63%	-8.44%	1.03x	4.21x	CA$-203.30 Million
2000	-15.54%	-3.28%	1.04x	4.55x	CA$-97.42 Million
2001	-10.38%	-2.14%	0.98x	4.96x	CA$-71.48 Million
2002	5.29%	1.08%	0.97x	5.04x	CA$-16.87 Million
2003	17.02%	3.63%	1.05x	4.47x	CA$25.03 Million
2004	27.20%	7.12%	1.22x	3.12x	CA$78.59 Million
2005	18.94%	4.78%	1.16x	3.42x	CA$44.46 Million
2006	0.00%	-2.05%	1.33x	0.00x	CA$-33.36 Million
2007	0.00%	3.99%	1.22x	0.00x	CA$72.74 Million
2008	0.00%	0.65%	1.14x	0.00x	CA$16.34 Million
2009	0.00%	3.59%	1.30x	0.00x	CA$81.80 Million
2010	45.74%	2.50%	1.04x	17.65x	CA$40.39 Million
2011	-62.91%	-1.45%	1.14x	37.89x	CA$-35.23 Million
2012	114.63%	3.08%	1.13x	33.08x	CA$57.19 Million
2013	14.13%	0.67%	0.42x	49.47x	CA$1.55 Million
2014	0.00%	-2.30%	0.43x	0.00x	CA$-18.50 Million
2015	134.83%	24.60%	0.92x	5.97x	CA$214.87 Million
2016	20.29%	3.34%	1.07x	5.66x	CA$17.98 Million
2017	1.65%	0.19%	1.17x	7.24x	CA$-10.76 Million
2018	25.19%	2.83%	1.25x	7.11x	CA$19.14 Million
2019	24.81%	2.53%	1.27x	7.70x	CA$17.09 Million
2020	42.27%	4.91%	1.15x	7.51x	CA$41.37 Million
2021	11.29%	0.99%	1.30x	8.83x	CA$1.31 Million
2022	69.07%	5.69%	1.56x	7.76x	CA$59.48 Million
2023	38.65%	2.60%	1.94x	7.65x	CA$25.19 Million
2024	60.48%	5.13%	2.04x	5.79x	CA$62.77 Million
2025	25.89%	5.82%	1.56x	2.86x	CA$59.32 Million

Industry Comparison

This section compares Extendicare Inc's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $216,353,386
Average return on equity (ROE) among peers: -9.17%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Extendicare Inc (EXE)	CA$373.37 Million	9.95%	1.86x	$2.32 Billion
HealWELL AI Inc. (AIDX)	$73.67 Million	-35.69%	0.70x	$183.88 Million
CareRx Corp (CRRX)	$14.95 Million	308.35%	24.26x	$146.41 Million
dentalcorp Holdings Ltd (DNTL)	$1.74 Billion	-4.93%	0.89x	$1.52 Billion
Medical Facilities Corporation (DR)	$78.69 Million	0.02%	2.29x	$224.71 Million
Element Lifestyle Retirement Inc (ELM)	$-470.32K	0.00%	0.00x	$509.83K
Jack Nathan Medical Corp (JNH)	$76.20K	-23.73%	0.10x	$65.29
Nova Leap Health Corp (NLH)	$19.04 Million	-1.00%	0.23x	$23.37 Million
NeuPath Health Inc (NPTH)	$21.65 Million	-19.24%	1.08x	$25.20 Million
Premier Health of America Inc (PHA)	$4.08 Million	-306.33%	17.09x	$401.58K

About Extendicare Inc

TO:EXE Canada Medical Care Facilities

Market Cap

$2.32 Billion

CA$3.21 Billion CAD

Market Cap Rank

#5838 Global

#192 in Canada

Share Price

CA$33.82

Change (1 day)

+2.42%

52-Week Range

CA$12.27 - CA$34.30

All Time High

CA$34.30